Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

From Structural Studies to HCV Vaccine Design

Viruses(2021)10.3390/v13050833Source: DataRank Database

From Structural Studies to HCV Vaccine Design is a research paper published in Viruses (2021). On theSindex it has a DataRank of 0. It has been cited 21 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access21 citations

Download PDF

Cite:

Linked data & code

uniprot nct pdb

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (6 grants)Impact (FWCI 1.53)OA: goldTopics (70)IDs (PubMed, PMC, OpenAlex)Annotations (3)SDGs (2)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (3)

Mansun Law ORCID,N. Tzarum ORCID,Itai Yechezkel

Live enrichment

PubMed:34064532 PMC:PMC8147963 OpenAlex:https://openalex.org/W3157973676

National Institutes of Health

Grant: AI123365

National Institutes of Health

Grant: AI123861

NIAID NIH HHS

Grant: R01 AI123365

NIAID NIH HHS

Grant: U19 AI123861

National Institutes of Health

Grant: 5U19AI123861-04

Cooperative Center for the study of HCV antibody responses and vaccine antigens

National Institutes of Health

Grant: 5R01AI123365-04

Structure and function of Hepacivirus envelope glycoprotein

FWCI

1.53

Citation Percentile

0.8%

Citation Trend

2021

2022

2023

2024

2025

2026

goldLicense: cc-by

journalhttps://www.mdpi.com/1999-4915/13/5/833/pdf

publisherhttps://www.mdpi.com/1999-4915/13/5/833/pdf

journalhttps://doi.org/10.3390/v13050833

repositoryhttps://pubmed.ncbi.nlm.nih.gov/34064532

repositoryhttps://doaj.org/article/07c625b36fae49c5b835d0d6274001e1

Fields of Study

Hepatitis C virus researchMonoclonal and Polyclonal Antibodies Researchvaccines and immunoinformatics approaches0301 basic medicine03 medical and health sciencesAnimalsAntibodies, NeutralizingCross ReactionsEpitopesGenotypeHepacivirusHepatitis C AntibodiesHepatitis C AntigensHumansMiceVaccine DevelopmentVaccine EfficacyViral Hepatitis Vaccines

MeSH Terms

Vaccine DevelopmentVaccine EfficacyAnimalsEpitopesCross ReactionsGenotypeHumansViral Hepatitis VaccinesHepacivirusHepatitis C AntigensHepatitis C AntibodiesMiceAntibodies, Neutralizing

Keywords

VirologyEpitopeAntigenHepatitis C virusImmune systemImmunologyVaccinationRational designAntibodyMedicineBiologyVirusGeneticsHepatitis C virus (HCV)E2E1Vaccine designNeutralizing AntibodiesStructural StudiesEnvelope GlycoproteinsVh1-69E1e2 ComplexNeutralization FaceViral Hepatitis VaccinesGenotypeVaccine EfficacyReviewHepacivirusCross ReactionsHepatitis C AntibodiesMicrobiologyAntibodies, NeutralizingQR1-502EpitopesMiceVaccine DevelopmentAnimalsHumansHepatitis C Antigens

Sustainable Development Goals

SDG 3: 3. Good healthSDG 0: Good health and well-being

From Structural Studies to HCV Vaccine Design

FAIR Checklist

Authors (3)

Funding (6 grants)

Impact

Open Access

Topics

Annotations (Europe PMC)